Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Gilliland

Showing results (111-120 of 182) with videos related to

Pageof 19
Sort By:
Cancer Cell|February 16, 2005
Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutationsM Golam Mohi, Ifor R Williams, Charles R Dearolf, et al.
Blood|June 29, 2006
JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation modelThomas Mercher, Gerlinde Wernig, Sandra A Moore, et al.
Cancer Cell|September 6, 2007
FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathwaySumin Kang, Shaozhong Dong, Ting-Lei Gu, et al.
Blood|December 17, 2008
High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patientsJeffrey W Tyner, Heidi Erickson, Michael W N Deininger, et al.
Blood|July 21, 2005
The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFRbeta and FIP1L1-PDGFRalpha in vitro and in vivoElizabeth H Stover, Jing Chen, Benjamin H Lee, et al.
Oncogene|August 24, 2005
FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse modelBenjamin H Lee, Ifor R Williams, Ema Anastasiadou, et al.
Immunity|April 13, 2022
The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockadeLisa Cucolo, Qingzhou Chen, Jingya Qiu, et al.
Blood|August 30, 2011
Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndromeMadhu S Kumar, Anupama Narla, Atsushi Nonami, et al.
Molecular Cancer Therapeutics|May 24, 2013
Preclinical evaluation of the WEE1 inhibitor MK-1775 as single-agent anticancer therapyAmy D Guertin, Jing Li, Yaping Liu, et al.
Cancer Cell|October 16, 2007
FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemiaBenjamin H Lee, Zuzana Tothova, Ross L Levine, et al.
Pageof 19

Showing results (111-120 of 182) with videos related to

Sort By:
Pageof 19
Cancer Cell|February 16, 2005
Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutationsM Golam Mohi, Ifor R Williams, Charles R Dearolf, et al.
Blood|June 29, 2006
JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation modelThomas Mercher, Gerlinde Wernig, Sandra A Moore, et al.
Cancer Cell|September 6, 2007
FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathwaySumin Kang, Shaozhong Dong, Ting-Lei Gu, et al.
Blood|December 17, 2008
High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patientsJeffrey W Tyner, Heidi Erickson, Michael W N Deininger, et al.
Blood|July 21, 2005
The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFRbeta and FIP1L1-PDGFRalpha in vitro and in vivoElizabeth H Stover, Jing Chen, Benjamin H Lee, et al.
Oncogene|August 24, 2005
FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse modelBenjamin H Lee, Ifor R Williams, Ema Anastasiadou, et al.
Immunity|April 13, 2022
The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockadeLisa Cucolo, Qingzhou Chen, Jingya Qiu, et al.
Blood|August 30, 2011
Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndromeMadhu S Kumar, Anupama Narla, Atsushi Nonami, et al.
Molecular Cancer Therapeutics|May 24, 2013
Preclinical evaluation of the WEE1 inhibitor MK-1775 as single-agent anticancer therapyAmy D Guertin, Jing Li, Yaping Liu, et al.
Cancer Cell|October 16, 2007
FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemiaBenjamin H Lee, Zuzana Tothova, Ross L Levine, et al.
Pageof 19